Biventricular Intravascular Microaxial Blood Pumps and Immunosuppression as a Bridge to Recovery in Giant Cell Myocarditis

Janet I Ma; Enrico Ammirati; Michela Brambatti; Eric Adler

doi:10.1016/j.jaccas.2020.05.107

Biventricular Intravascular Microaxial Blood Pumps and Immunosuppression as a Bridge to Recovery in Giant Cell Myocarditis

JACC Case Rep. 2020 Aug 19;2(10):1484-1488. doi: 10.1016/j.jaccas.2020.05.107. eCollection 2020 Aug.

Authors

Janet I Ma¹, Enrico Ammirati², Michela Brambatti¹, Eric Adler¹

Affiliations

¹ Division of Cardiology, Department of Medicine, University of California, Sulpizio Cardiovascular Center, San Diego, California.
² Transplant Center and De Gasperis Cardio Center, Niguarda Hospital, Milano, Italy.

Abstract

We report a case of giant cell myocarditis in a 76-year-old patient managed with combined immunosuppression and biventricular intravascular microaxial blood pumps. This case highlights a feasible approach for managing such patients who are not candidates for transplantation or durable ventricular assist devices. (Level of Difficulty: Intermediate.).

Keywords: BNP, B-type natriuretic peptide; CMV, cytomegalovirus; EMB, endomyocardial biopsy; GCM, giant cell myocarditis; HF, heart failure; LVEF, left ventricular ejection fraction; TTE, transthoracic echocardiogram; acute heart failure; cardiac assist devices; hemodynamics; inotropes.

Publication types

Case Reports